SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-015864
Filing Date
2021-07-01
Accepted
2021-07-01 17:12:11
Documents
14
Period of Report
2021-07-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50742
2 ex99-1.htm EX-99.1 8855
  Complete submission text file 0001493152-21-015864.txt   296985

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ensc-20210701.xsd EX-101.SCH 3768
4 XBRL DEFINITION FILE ensc-20210701_def.xml EX-101.DEF 28267
5 XBRL LABEL FILE ensc-20210701_lab.xml EX-101.LAB 37818
6 XBRL PRESENTATION FILE ensc-20210701_pre.xml EX-101.PRE 26473
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6944
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 211066913
SIC: 2834 Pharmaceutical Preparations